Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of transcriptional control in multiple system atrophy.
POLG mutations associated with remitting/relapsing neurological events.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
A case of exacerbated multiphasic disseminated encephalomyelitis after interferon beta treatment.
Managed care aspects of managing multiple sclerosis.
Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
The Potential of Metabolic Imaging.
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.
New methods for analysis of oxysterols and related compounds by LC-MS.
Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Bringing CLARITY to gray matter atrophy.
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitis.
The clinical overlap of multiple sclerosis and headache.
Pages
« first
‹ previous
…
419
420
421
422
423
424
425
426
427
…
next ›
last »